
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
Beauty Health Co (SKIN)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: SKIN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $1.88
1 Year Target Price $1.88
0 | Strong Buy |
0 | Buy |
7 | Hold |
2 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -45.9% | Avg. Invested days 22 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 259.99M USD | Price to earnings Ratio - | 1Y Target Price 1.88 |
Price to earnings Ratio - | 1Y Target Price 1.88 | ||
Volume (30-day avg) 9 | Beta 1.2 | 52 Weeks Range 0.78 - 2.56 | Updated Date 08/29/2025 |
52 Weeks Range 0.78 - 2.56 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-07 | When - | Estimate -0.06 | Actual 0.03 |
Profitability
Profit Margin -6.13% | Operating Margin (TTM) -3.45% |
Management Effectiveness
Return on Assets (TTM) -4.45% | Return on Equity (TTM) -26.55% |
Valuation
Trailing PE - | Forward PE 102.04 | Enterprise Value 423454809 | Price to Sales(TTM) 0.84 |
Enterprise Value 423454809 | Price to Sales(TTM) 0.84 | ||
Enterprise Value to Revenue 1.37 | Enterprise Value to EBITDA 20.45 | Shares Outstanding 126825000 | Shares Floating 81549999 |
Shares Outstanding 126825000 | Shares Floating 81549999 | ||
Percent Insiders 9.98 | Percent Institutions 86.12 |
Upturn AI SWOT
Beauty Health Co
Company Overview
History and Background
Beauty Health Co, formerly known as HydraFacial, was founded in 2016. It has grown to be a global leader in the beauty health category by developing and commercializing non-invasive aesthetic technologies and products. They aim to deliver beauty health experiences by connecting skincare professionals with consumers.
Core Business Areas
- HydraFacial: Develops, manufactures, and markets the HydraFacial system, a non-invasive skincare treatment that cleanses, exfoliates, extracts, hydrates, and provides antioxidant protection. This is their primary revenue driver.
- Consumer Products: Offers a range of skincare products designed for at-home use to complement the HydraFacial treatments and maintain skin health.
Leadership and Structure
Andrew Stanleick is the CEO. The organizational structure includes departments for sales, marketing, research & development, operations, and finance. They are publicly traded on NASDAQ.
Top Products and Market Share
Key Offerings
- HydraFacial System: The HydraFacial system is the core product, generating the majority of the company's revenue. It uses proprietary serums and a delivery system for skin resurfacing. Competitors include microdermabrasion, chemical peels, and other facial treatments from companies like Allergan Aesthetics and L'Oru00e9al. Precise market share data is dynamic, but it is estimated between 20% and 30% of the professional skincare treatment market that includes similar machines and services.
- At-Home Products: The company offers a range of skincare products to maintain skin health at home, often used as a complement to HydraFacial treatments. Revenue from this segment is smaller compared to the HydraFacial system. Competitors include brands like The Ordinary and Drunk Elephant
Market Dynamics
Industry Overview
The beauty health industry is experiencing significant growth, driven by increasing consumer awareness of skincare and technological advancements. The market is competitive, with a mix of established players and emerging brands.
Positioning
Beauty Health Co positions itself as a leader in the beauty health category, focusing on non-invasive treatments and personalized skincare solutions. Their competitive advantage lies in the HydraFacial system's patented technology and brand recognition.
Total Addressable Market (TAM)
The global aesthetic medicine market, which encompasses Beauty Health's core business, is projected to reach hundreds of billions of dollars. HydraFacial is positioned to grow within this market through expanded product offerings and strategic partnerships, and increased awareness and popularity through influencers. Their TAM includes professional skincare providers and at-home consumers.
Upturn SWOT Analysis
Strengths
- Strong brand recognition (HydraFacial)
- Proprietary technology
- Recurring revenue model (consumables)
- Global distribution network
- Partnerships with leading aesthetic providers
Weaknesses
- High dependence on HydraFacial system sales
- Premium pricing may limit accessibility
- Competition from established players
- Potential for imitation products
- Fluctuations in consumer spending on discretionary items
Opportunities
- Expanding product line (at-home products)
- Geographic expansion (untapped markets)
- Strategic acquisitions
- Partnerships with influencers
- Increased focus on personalized skincare solutions
Threats
- Economic downturns affecting consumer spending
- Increased competition from alternative treatments
- Changes in consumer preferences and trends
- Regulatory changes affecting the beauty industry
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- ALLY
- LRLCY
- EL
Competitive Landscape
Beauty Health Co has a strong brand and a differentiated product offering. However, it faces competition from larger, more established players in the beauty industry. Beauty Health Co's advantages include its proprietary technology and focus on non-invasive treatments.
Growth Trajectory and Initiatives
Historical Growth: Beauty Health Co has experienced significant growth in recent years, driven by the popularity of the HydraFacial system and increasing consumer demand for skincare treatments. Growth data needs to be added here.
Future Projections: Analyst estimates suggest continued growth for Beauty Health Co, driven by product innovation, geographic expansion, and strategic partnerships. Data from Analyst Estimates needs to be provided here.
Recent Initiatives: Recent initiatives include expanding the product line with new serums and at-home products, increasing marketing efforts, and forging partnerships with influencers and retailers.
Summary
Beauty Health Co demonstrates some strengths, like a strong brand and recurring revenue, but weaknesses in profitability must be addressed. Its market positioning is unique, yet threats from larger competitors and economic factors persist. Strategic initiatives, particularly related to geographic and product expansion, will drive the company's long-term success. Monitoring consumer preferences and adjusting business strategies accordingly are essential for continued growth and competitive positioning.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered investment advice. Actual results may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Beauty Health Co
Exchange NASDAQ | Headquaters Long Beach, CA, United States | ||
IPO Launch date 2020-11-24 | President, CEO & Director Ms. Marla Malcolm Beck | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 769 | Website https://www.beautyhealth.com |
Full time employees 769 | Website https://www.beautyhealth.com |
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.